Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of E3 ubiquitin ligases in the development and progression of glioblastoma
Luke Humphreys, Paul Smith, Zhuoyao Chen, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 522-537
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

The ubiquitin system: from cell signalling to disease biology and new therapeutic opportunities
Rune Busk Damgaard
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 423-426
Open Access | Times Cited: 182
The role of Ubiquitination in Apoptosis and Necroptosis
Jamie Z. Roberts, Nyree Crawford, Daniel B. Longley
Cell Death and Differentiation (2021) Vol. 29, Iss. 2, pp. 272-284
Open Access | Times Cited: 139
TRIM7 modulates NCOA4-mediated ferritinophagy and ferroptosis in glioblastoma cells
Kaiqiang Li, Bingyu Chen, Aibo Xu, et al.
Redox Biology (2022) Vol. 56, pp. 102451-102451
Open Access | Times Cited: 79
Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT
Jianing Tang, Guo Long, Kuan Hu, et al.
Advanced Science (2023) Vol. 10, Iss. 33
Open Access | Times Cited: 43
PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
Zijie Gao, Jianye Xu, Fan Yang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 38
Recruitment of FBXO22 for targeted degradation of NSD2
Yan Nie, John R. Tabor, Jianping Li, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 12, pp. 1597-1607
Closed Access | Times Cited: 14
TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO
Yike Chen, Xiaohui Xu, Kaikai Ding, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
The E3 ligase TRIM7 suppresses the tumorigenesis of gastric cancer by targeting SLC7A11
Qishuai Chen, Tong-Tong Zhang, Runzhi Zeng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
DTX3L induced NLRP3 ubiquitination inhibit R28 cell pyroptosis in OGD/R injury
Ziyu Zhou, Lei Shang, Qí Zhāng, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 3, pp. 119433-119433
Open Access | Times Cited: 21
Revolutionizing Drug Targeting Strategies: Integrating Artificial Intelligence and Structure-Based Methods in PROTAC Development
Mohd Danishuddin, Mohammad Sarwar Jamal, Kyoung Seob Song, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1649-1649
Open Access | Times Cited: 17
The role of ubiquitination in health and disease
Yan Liao, Wangzheqi Zhang, Yang Liu, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 7
Caspase-8 in inflammatory diseases: a potential therapeutic target
Wangzheqi Zhang, Chenglong Zhu, Yan Liao, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
Juliana Brandstetter Vilar, Markus Christmann, Maja Tomičić
Cancers (2022) Vol. 14, Iss. 10, pp. 2416-2416
Open Access | Times Cited: 24
TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance
Yongxu Li, Tiepeng Wang, Quan Wan, et al.
Cancer Research (2022) Vol. 82, Iss. 19, pp. 3573-3587
Open Access | Times Cited: 24
Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases
Bo Han, Mengfei Wang, Jiayi Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115613-115613
Closed Access | Times Cited: 15
Target protein degradation by protacs: A budding cancer treatment strategy
Diksha Choudhary, Amritpal Kaur, Pargat Singh, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108525-108525
Closed Access | Times Cited: 12
The Role and Mechanisms of Ubiquitin-Proteasome System-Mediated Ferroptosis in Neurological Disorders
Xin Liu, Wei Wang, Qunhua Nie, et al.
Neuroscience Bulletin (2025)
Closed Access
Decoding oncogenic secrets of regulator of chromosome condensation 1: A breakthrough mechanistic evidence from breast and lung cancer models
Mohamed El‐Tanani, Shakta Mani Satyam, Syed Arman Rabbani, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319748-e0319748
Open Access
RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitination
Lu Chen, Hongda Liu, Tianyu Liu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Modulators of the ubiquitin–proteasome system from natural products: chemical structures and their potential for drug discovery
Yuki Hitora, Sachiko Tsukamoto
Natural Product Reports (2025)
Closed Access
Biofilm Biology to Brain Health: Harnessing Microbial Wisdom to Uncover Amyloid Dissociating Bifunctional Nano Chaperones for Alzheimer’s Therapeutics
Shiwani Randhawa, Trilok Chand Saini, Manik Bathla, et al.
ACS Chemical Neuroscience (2025)
Closed Access
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
Andrej Porčnik, Metka Novak, Barbara Breznik, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5141-5141
Open Access | Times Cited: 24
The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression
Ye Yuan, Lihong Wang, Xianxian Zhao, et al.
Cancer Communications (2022) Vol. 42, Iss. 9, pp. 868-886
Open Access | Times Cited: 17
Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase
Anastasia A. Sachkova, Daria V. Andreeva, Alexander S. Tikhomirov, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2829-2829
Open Access | Times Cited: 16
The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer
Zhen Ye, Jingru Yang, Hanming Jiang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top